Tissuegenic Implants with ECM-Mimetic Matrix for Tissue Integration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current surgical implants that incorporate cells, growth factors, and a physical matrix lack effective methods for integrating and stabilizing these components within the body's tissue compartments, leading to inadequate tissue regeneration and integration.
Innovation Solution
Development of surgical implants that utilize a combination of cells, growth factors, and a physical matrix, specifically designed to interact with the extracellular matrix (ECM) components such as glycosaminoglycans, proteoglycans, and collagen, to enhance tissue integration and regeneration by mimicking natural tissue structures.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If surgical implants incorporate cells, growth factors, and a physical matrix, then tissue regeneration capability is improved, but integration and stabilization with body tissue compartments is insufficient
Solution Approach 1:
The patent modifies the physical and chemical parameters of the implant matrix to match native ECM properties, including mechanical stiffness, porosity, and biochemical composition. This enables the implant to better integrate with surrounding tissue compartments while maintaining structural stability and supporting cell growth factors.
Solution Approach 2:
The implant is designed as a composite structure combining synthetic or natural polymer matrices with embedded biological components (cells, growth factors, and ECM-mimetic structures). This composite approach allows simultaneous achievement of mechanical stability and biological integration functionality.
2Ease of operation
If surgical implants use a physical matrix scaffold, then cell migration and interaction are supported, but effective stabilization within tissue compartments is lacking
Solution Approach 1:
The implant matrix is designed with controlled porosity and interconnected pore structures that facilitate cell infiltration, migration, and nutrient diffusion while maintaining overall structural integrity. The pore size and distribution are optimized to support tissue ingrowth without compromising mechanical stability.
Solution Approach 2:
The patent introduces ECM-mimetic components and surface modification layers that act as intermediaries between the implant matrix and host tissue. These intermediary structures promote cellular attachment and tissue integration while stabilizing the implant within the tissue compartment.
Data Source
AI summary
The disclosure provides implants containing a plurality of particles containing at least one population of viable tissuegenic cells adherent to and resident in the growth-conductive matrix or at least viable population of tissuegenic cells caused to be in contact with the growth-conductive matrix; methods to fabricate implants; methods of fabricating the implants; and use of the implants in tissue repair.